Description
Ajovy (fremanezumab) is a fully humanized monoclonal antibody targeting CGRP for the preventive treatment of migraine.
$668.74
CGRP monoclonal antibody for migraine
Ajovy (fremanezumab) is a fully humanized monoclonal antibody targeting CGRP for the preventive treatment of migraine.
Reviews
There are no reviews yet.